Source: Virtual Congress 2020 – Management issues in thoracic oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Martinez Mesa (Malaga, Spain), N. Reina Marfil (Malaga, Spain), E. Cabrera Cesar (Malaga, Spain), A. Aguilar Galvez (Malaga, Spain), E. Sanchez (Malaga, Spain), M. Fernandez Aguirre (Malaga, Spain). Evolution in the pathological study of lung cancer. 2918

Member's Comments

No comment yet.

Related content which might interest you: Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 Epigenetics and lung cancer Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Pathological profile of lung cancer in Tunisia Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Does the lung function affect the survival time in patients with resected non-small cell lung cancer? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007 A study of the public‘s awareness of the causation of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 184s Year: 2005 Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009